Product Reports Resources Pricing Login Book a demo

Amoy Diagnostic

Biotech & Life Sciences · Dongcheng District, China · Founded 2008

Amoy Diagnostic focuses on molecular diagnostics for oncology precision medicine MoreLess

Amoy Diagnostics is a pioneering company in the field of cancer diagnostics, dedicated to revolutionizing cancer care through precision oncology. The company focuses on providing innovative and accurate diagnostic solutions that enable personalized treatment plans for cancer patients. Operating in the global healthcare market, Amoy Diagnostics serves a diverse range of clients including hospitals, research institutions, and healthcare providers. The business model revolves around the development and commercialization of advanced diagnostic tests, particularly those that utilize genomic information to tailor cancer treatments. Revenue is generated through the sale of diagnostic kits, partnerships with healthcare institutions, and collaborations with pharmaceutical companies. Amoy Diagnostics is committed to making precision medicine accessible to all, ensuring equitable access to cutting-edge cancer diagnostics and treatments.

Keywords: cancer diagnostics, precision oncology, genomic testing, personalized treatment, healthcare innovation, diagnostic kits, global healthcare, equitable access, advanced diagnostics, pharmaceutical partnerships.

Valuation $500M–1B
Revenue $100–500M
Headcount 100–500
Total funding $10–50M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Amoy Diagnostic and the history behind them.

Company overview

Amoy Diagnostic company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2008
Headquarters
Dongcheng District, China
Employees
112
Open positions
1
Dealroom signal
37.3
Investment activity
1 companies · latest Oct 2025
Capital deployed
$6.9M
Preferred round
SERIES B
client focusb2bsub industryBioTechnologysectorIntellectual PropertysectorTestingindustryHealthsectorBiotechnologysectorOncologysectorPrecision MedicinesectorHealth DiagnosticssectorSpinoutsectorBiotech and Pharmasectormedical testingsectorDT and LSsectorscience-based

Valuation & funding

Amoy Diagnostic funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPOExit Aug 2017 $0 Undisclosed
SERIES BEquity / VC Jan 2015 $6M $24M Undisclosed
SERIES BEquity / VC Sep 2013 $4.4M $18M Undisclosed
SPINOUTOther financing Jan 2008 $0 Xiamen University
Showing 4 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthEBITDAMarginProfitMarginR&D
2026 $172M +4.4% $68M 39.6% $50M 29.3% $24M
2025 $165M +8% $68M 41.1% $50M 30.2% $24M
2024 $152M +6.3% $52M 34.1% $35M 23% $30M
2023 $143M +23.9% $50M 34.9% $28M
2022 $116M -8.2% $34M 29.3%
2021 $126M +25.9% $41M 32.5%
2020 $100M $33M 32.6%
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Amoy Diagnostic website traffic

Latest recorded traffic for Amoy Diagnostic is 2.2K monthly website visits, up 100% over the last three months. Amoy Diagnostic's team grew 2.8% over the past year.

Latest monthly visits2.2K 3-month web change+100% 1-year team growth+2.8%
Monthly website visits89 observations · Dec 2018–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Hiring

Open positions at Amoy Diagnostic

Current openings linked to this company in Dealroom.

1 distinct opening shownExplore hiring signals →

Comparisons

Amoy Diagnostic compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Capital deployed

Amoy Diagnostic investments and acquisitions

Recent portfolio relationships for companies that also act as investors or acquirers.

Talent graph

Amoy Diagnostic's talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

1 investor on Amoy Diagnostic's cap table

Sourced from Dealroom's funding and investor records.

Other known 1 additional known investor
Xiamen University

Global footprint

Where Amoy Diagnostic has talent and traffic

Workforce by country
13 countries with
team presence
🇨🇳 China63.9%
🇸🇬 Singapore11.5%
🇩🇪 Germany3.3%
🇺🇸 United States3.3%
🇦🇺 Australia3.3%
Top 5 of 13 shown

In the news

Latest news about Amoy Diagnostic

Recent press, funding announcements, and product moves mentioning Amoy Diagnostic — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Amoy Diagnostic

An AI-synthesized read of the highest-engagement posts about Amoy Diagnostic on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Amoy Diagnostic’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.